Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

AURAAURA
Showing 8 of 19 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in AURA BIOSCIENCES INC

Yes. Northern Trust holds 549,462 shares of AURA (Aura Biosciences), worth $3.9M, as of its Q2 2026 13F filing. It increased the position by 118,940 shares (+27.6%) from Q1 2026. Northern Trust has held AURA since Q4 2021, across 19 quarterly 13F filings.

Current Value

$3.9M

Current Shares

549,462

Total Value Change

+$655,598

Total Shares Change

+185,199

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
549,462
+27.6%
$3.9M0.0%$7.10
33
2026-Q1
Increased
430,522
+4.3%
$2.9M0.0%$6.24
27
2025-Q4
Decreased
412,809
-4.8%
$2.2M0.0%$5.49
0
2025-Q3
Increased
433,641
+17.1%
$2.7M0.0%$6.17
31
2025-Q2
Decreased
370,472
-1.1%
$2.3M0.0%$6.28
0
2025-Q1
Decreased
374,518
-3.3%
$2.2M0.0%$6.34
0
2024-Q4
Increased
387,269
+6.3%
$3.2M0.0%$8.13
28
2024-Q3
Increased
364,263
+24.6%
$3.2M0.0%$9.03
32

Other major holders of AURA: CITADEL ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used